Nanomedicine News RSS Feed - Nanomedicine

ONXEO Provides Update on Nanoparticle-Based Livatag Phase III Trial for Hepatocellular Carcinoma

ONXEO Provides Update on Nanoparticle-Based Livatag Phase III Trial for Hepatocellular Carcinoma

Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, updates on the clinical development status of ReLive , the Livatag®phase III trial in the treatment of hepatocellular carcinoma. [More]
WHO Teleconference: Novavax Reports Top-Line Data from Ebola GP Recombinant Nanoparticle Vaccine Clinical Trial

WHO Teleconference: Novavax Reports Top-Line Data from Ebola GP Recombinant Nanoparticle Vaccine Clinical Trial

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced positive top-line data from a Phase 1 clinical trial of its Ebola virus glycoprotein (GP) recombinant nanoparticle vaccine candidate adjuvanted with Matrix-M™ as part of the World Health Organization’s (WHO) Fifth Teleconference on Ebola Vaccine Clinical Trials. [More]
Cerulean Commences Dosing in CRLX101-Weekly Paclitaxel Phase 1b Clinical Trial for Relapsed Ovarian Cancer

Cerulean Commences Dosing in CRLX101-Weekly Paclitaxel Phase 1b Clinical Trial for Relapsed Ovarian Cancer

Cerulean Pharma Inc. today announced that the first patient has been dosed in an open label Phase 1b clinical trial of its lead product candidate, CRLX101, in combination with weekly paclitaxel in patients with relapsed ovarian cancer by the University of Virginia School of Medicine. This trial is being conducted by Cerulean in collaboration with the GOG Foundation under the direction of principal investigator, Carolyn N. Krasner, M.D., of the Massachusetts General Hospital Cancer Center. [More]
Novel Method Utilizes Nanoparticles and UV Light to Isolate, Extract Contaminants

Novel Method Utilizes Nanoparticles and UV Light to Isolate, Extract Contaminants

Many human-made pollutants in the environment resist degradation through natural processes, and disrupt hormonal and other systems in mammals and other animals. Removing these toxic materials — which include pesticides and endocrine disruptors such as bisphenol A (BPA) — with existing methods is often expensive and time-consuming. [More]
MIT Scholars Engaged in Nanomaterials Study for Drug Delivery, Biofuel Catalysts

MIT Scholars Engaged in Nanomaterials Study for Drug Delivery, Biofuel Catalysts

From wet chemistry to computer simulations, this year's Materials Processing Center-Center for Materials Science and Engineering Summer Scholars are engaged in MIT research projects targeting stronger materials, more efficient drug delivery, and catalysts for biofuel production. [More]

NanoLock Signs Agreement to License its Nano-Polymer Additive that Protects Against Microbial Infection

NanoLock Ltd. entered this week into a license agreement with Hadasit Medical Research Services & Development Ltd. (Jerusalem, Israel), Hadassah Ein-Kerem Medical Center Jerusalem, and Yissum Research Development Com... [More]
Sticky-Flare Nanotechnology Reveals RNA Misregulation in Living Cells

Sticky-Flare Nanotechnology Reveals RNA Misregulation in Living Cells

RNA is a fundamental ingredient in all known forms of life -- so when RNA goes awry, a lot can go wrong. RNA misregulation plays a critical role in the development of many disorders, such as mental disability, autism and cancer. [More]
New Electron Microscopy Method Allows Nanoscale Studies of Breast Tumors in Their Native Liquid Environment

New Electron Microscopy Method Allows Nanoscale Studies of Breast Tumors in Their Native Liquid Environment

HER2 membrane proteins play a special role in certain types of breast cancer: amplified levels of HER2 drive unrestricted cell growth. HER2-tailored antibody-based therapeutics aim to prevent cancer cell growth. However, two-thirds of HER2 positive breast cancer patients develop resistance against HER2-targeting drugs. [More]
Nanoparticles May Help Tackle Acne

Nanoparticles May Help Tackle Acne

GW researcher and dermatologist, Adam Friedman, M.D., and colleagues, find that the release of nitric oxide over time may be a new way to treat and prevent acne through nanotechnology. [More]
Remedium's Hemogrip Patch to Help Stop Bleeding Receives FDA Clearance

Remedium's Hemogrip Patch to Help Stop Bleeding Receives FDA Clearance

Remedium Technologies, a medical device company and University of Maryland spin-out advancing the standard of care for treating uncontrolled hemorrhage, today announces the 510(k) clearance of its Hemogrip™ Patch by the U.S. Food and Drug Administration (FDA). [More]